Multiparametric MRI of prostate cancer: An update on state‐of‐the‐art techniques and their performance in detecting and localizing prostate cancer
暂无分享,去创建一个
S. Maier | F. Fennessy | C. Tempany | L. Panych | J. Hegde | R. Mulkern | Andrey Fedorov
[1] Fl,et al. United states. , 2019, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[2] J. Kurhanewicz,et al. Multiparametric 3T endorectal mri after external beam radiation therapy for prostate cancer , 2012, Journal of magnetic resonance imaging : JMRI.
[3] S. Lipsitz,et al. Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States , 2012, Cancer.
[4] T. Metens,et al. What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? , 2012, European Radiology.
[5] Rajiv Chopra,et al. The feasibility of endorectal MR elastography for prostate cancer localization , 2011, Magnetic resonance in medicine.
[6] Thomas Hambrock,et al. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil. , 2011, European urology.
[7] Baris Turkbey,et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. , 2011, The Journal of urology.
[8] A. Padhani. Integrating multiparametric prostate MRI into clinical practice , 2011, Cancer imaging : the official publication of the International Cancer Imaging Society.
[9] Steven P Sourbron,et al. On the scope and interpretation of the Tofts models for DCE‐MRI , 2011, Magnetic resonance in medicine.
[10] G. Cowin,et al. 16 T Diffusion microimaging of fixed prostate tissue: Preliminary findings , 2011, Magnetic resonance in medicine.
[11] Yousef Mazaheri,et al. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. , 2011, Radiology.
[12] Derya Yakar,et al. Initial Results of 3-Dimensional 1H-Magnetic Resonance Spectroscopic Imaging in the Localization of Prostate Cancer at 3 Tesla: Should We Use an Endorectal Coil? , 2011, Investigative radiology.
[13] H. Huisman,et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. , 2011, Radiology.
[14] François Cornud,et al. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2‐weighted, dynamic contrast‐enhanced and diffusion‐weighted imaging , 2011, BJU international.
[15] B. Carey,et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.
[16] Xuna Zhao,et al. A feasibility study of MR elastography in the diagnosis of prostate cancer at 3.0T , 2011, Acta radiologica.
[17] F. Beuvon,et al. Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer , 2011, Prostate Cancer and Prostatic Diseases.
[18] S. Lipsitz,et al. Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Baris Turkbey,et al. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? , 2011, Radiology.
[20] Heinz-Peter Schlemmer,et al. Discriminating Cancer From Noncancer Tissue in the Prostate by 3-Dimensional Proton Magnetic Resonance Spectroscopic Imaging: A Prospective Multicenter Validation Study , 2011, Investigative radiology.
[21] M. Reiser,et al. MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer. , 2010, European journal of radiology.
[22] Aytekin Oto,et al. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. , 2010, Radiology.
[23] C. Bartolozzi,et al. Peripheral zone prostate cancer. Pre-treatment evaluation with MR and 3D 1H MR spectroscopic imaging: correlation with pathologic findings , 2010, Abdominal Imaging.
[24] A. Evans,et al. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. , 2010, Radiology.
[25] Brian B. Avants,et al. N4ITK: Improved N3 Bias Correction , 2010, IEEE Transactions on Medical Imaging.
[26] Piotr Kozlowski,et al. Comparison between population average and experimentally measured arterial input function in predicting biopsy results in prostate cancer. , 2010, Academic radiology.
[27] P. Choyke,et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. , 2010, Radiology.
[28] Kazuro Sugimura,et al. Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.
[29] D. Beyersdorff,et al. Differentiation of prostate cancer from normal prostate tissue: role of hotspots in pharmacokinetic MRI and histologic evaluation. , 2010, AJR. American journal of roentgenology.
[30] D. Dearnaley,et al. A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance. , 2009, European urology.
[31] A. Prando. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume , 2009 .
[32] Gary P Liney,et al. Correlation of ADC and T2 Measurements With Cell Density in Prostate Cancer at 3.0 Tesla , 2009, Investigative radiology.
[33] L. Turnbull,et al. Description of magnetic resonance imaging‐derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions , 2009, BJU international.
[34] Jason A Koutcher,et al. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. , 2009, Radiology.
[35] A. Evans,et al. Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[36] Matthias Taupitz,et al. Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters. , 2009, Radiology.
[37] Bin Wang,et al. Diffusion‐weighted imaging of prostate cancer: Correlation between apparent diffusion coefficient values and tumor proliferation , 2009, Journal of magnetic resonance imaging : JMRI.
[38] S. Haker,et al. Carr-Purcell-Meiboom-Gill imaging of prostate cancer: quantitative T2 values for cancer discrimination. , 2009, Magnetic resonance imaging.
[39] Gary Liney,et al. Correlation of diffusion‐weighted magnetic resonance data with cellularity in prostate cancer , 2009, BJU international.
[40] Katarzyna J Macura,et al. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. , 2009, Radiology.
[41] John Kurhanewicz,et al. Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. , 2009, European urology.
[42] M. Yaffe,et al. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. , 2008, Radiology.
[43] J. Geitung,et al. Prostate magnetic resonance imaging: Multiexponential T2 decay in prostate tissue , 2008, Journal of magnetic resonance imaging : JMRI.
[44] Yousef Mazaheri,et al. MR imaging of the prostate in clinical practice , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.
[45] K. Touijer,et al. The role of endorectal coil MRI in preoperative staging and decision-making for the treatment of clinically localized prostate cancer , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.
[46] Peter Boesiger,et al. Two-dimensional MR spectroscopy of healthy and cancerous prostates in vivo , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.
[47] John Kurhanewicz,et al. A clinical comparison of rigid and inflatable endorectal‐coil probes for MRI and 3D MR spectroscopic imaging (MRSI) of the prostate , 2008, Journal of magnetic resonance imaging : JMRI.
[48] T. Sone,et al. Age‐related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues , 2008, Journal of magnetic resonance imaging : JMRI.
[49] Jason A Koutcher,et al. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings. , 2008, Radiology.
[50] T. Scheenen,et al. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. , 2007, Radiology.
[51] H. Hricak,et al. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. , 2007, Radiology.
[52] Tristan Barrett,et al. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. , 2007, AJR. American journal of roentgenology.
[53] A. Hemal,et al. Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut‐off value to predict malignancy of the peripheral zone , 2007, NMR in biomedicine.
[54] Masoom A Haider,et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. , 2007, AJR. American journal of roentgenology.
[55] Thomas Hambrock,et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance. , 2007, Radiology.
[56] Esin Ozturk-Isik,et al. High‐speed 3T MR spectroscopic imaging of prostate with flyback echo‐planar encoding , 2007, Journal of magnetic resonance imaging : JMRI.
[57] Olivier Rouvière,et al. Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? , 2007, European Radiology.
[58] R. Lenkinski,et al. 3T MR of the prostate: Reducing susceptibility gradients by inflating the endorectal coil with a barium sulfate suspension , 2007, Magnetic resonance in medicine.
[59] Peter L Choyke,et al. Imaging prostate cancer: a multidisciplinary perspective. , 2007, Radiology.
[60] V. Pansadoro,et al. Contribution of the MR spectroscopic imaging in the diagnosis of prostate cancer in the peripheral zone , 2007, Abdominal Imaging.
[61] Takeo Ishigaki,et al. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. , 2007, European journal of radiology.
[62] H. Huisman,et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.
[63] A. Jackson,et al. Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.
[64] Stephan E Maier,et al. Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. , 2006, Magnetic resonance imaging.
[65] Olivier Rouvière,et al. Prostate MR imaging at high-field strength: evolution or revolution? , 2006, European Radiology.
[66] J. Kurhanewicz,et al. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. , 2005, Radiology.
[67] Dennis W J Klomp,et al. Optimal timing for in vivo 1H‐MR spectroscopic imaging of the human prostate at 3T , 2005, Magnetic resonance in medicine.
[68] M. Kattan,et al. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.
[69] R. Constable,et al. Measurement and correction of transmitter and receiver induced nonuniformities in vivo , 2005, Magnetic resonance in medicine.
[70] P. Carroll,et al. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. , 2004, Radiology.
[71] Arend Heerschap,et al. Fast acquisition‐weighted three‐dimensional proton MR spectroscopic imaging of the human prostate , 2004, Magnetic resonance in medicine.
[72] H. Hricak,et al. Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations. , 2004, Radiology.
[73] William Wells,et al. Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging; a multichannel statistical classifier. , 2003, Medical physics.
[74] John W. Fisher,et al. A Unified Variational Approach to Denoising and Bias Correction in MR , 2003, IPMI.
[75] J. Kurhanewicz,et al. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer , 2002, Journal of magnetic resonance imaging : JMRI.
[76] A. Renshaw,et al. Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. , 2002, Urology.
[77] B. Issa,et al. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging , 2002, Journal of magnetic resonance imaging : JMRI.
[78] Peter Gibbs,et al. Comparison of quantitative T2 mapping and diffusion‐weighted imaging in the normal and pathologic prostate , 2001, Magnetic resonance in medicine.
[79] Lawrence P. Panych,et al. Echo planar spectroscopic imaging , 2001 .
[80] D. Kacher,et al. Sensitivity profiles from an array of coils for encoding and reconstruction in parallel (SPACE RIP) , 2000, Magnetic resonance in medicine.
[81] D. Sodickson. Tailored SMASH image reconstructions for robust in vivo parallel MR imaging , 2000, Magnetic resonance in medicine.
[82] P. Carroll,et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.
[83] P. Boesiger,et al. SENSE: Sensitivity encoding for fast MRI , 1999, Magnetic resonance in medicine.
[84] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[85] A. Elster,et al. Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images. , 1999, Radiology.
[86] J. García-Segura,et al. In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology. , 1999, Magnetic resonance imaging.
[87] J. K. Kim,et al. In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia: localized proton magnetic resonance spectroscopy using external-body surface coil. , 1998, Magnetic resonance imaging.
[88] G P Liney,et al. Comparison of conventional single echo and multi‐echo sequences with a fast spin‐echo sequence for quantitative T2 mapping: Application to the prostate , 1996, Journal of magnetic resonance imaging : JMRI.
[89] P. Carroll,et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.
[90] P. Carroll,et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. , 1995, Radiology.
[91] P S Tofts,et al. Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.
[92] P. Carroll,et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. , 1994, Radiology.
[93] C W Piccoli,et al. Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. , 1994, Radiology.
[94] C. S. Poon,et al. Practical T2 quantitation for clinical applications , 1992, Journal of magnetic resonance imaging : JMRI.
[95] C. Tempany,et al. Invasion of the neurovascular bundle by prostate cancer: evaluation with MR imaging. , 1991, Radiology.
[96] R. Turner,et al. Echo‐planar imaging of diffusion and perfusion , 1991, Magnetic resonance in medicine.
[97] L P Panych,et al. Comparing the FAISE method with conventional dual‐echo sequences , 1991, Journal of magnetic resonance imaging : JMRI.
[98] R E Lenkinski,et al. Prostate: MR imaging with an endorectal surface coil. , 1989, Radiology.
[99] J. Martin,et al. Inflatable surface coil for MR imaging of the prostate. , 1988, Radiology.
[100] P. Bottomley. Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.
[101] R B Jeffrey,et al. Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging. , 1987, Radiology.
[102] S. Maier,et al. Apparent diffusion coefficient of line scan diffusion image in normal prostate and prostate cancer--comparison with single-shot echo planner image. , 2011, Magnetic resonance imaging.
[103] C. Kim,et al. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. , 2010, AJR. American journal of roentgenology.
[104] Kyung Ah Kim,et al. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study. , 2009, Radiology.
[105] H. Hricak,et al. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. , 2008, Radiology.
[106] G P Liney,et al. In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI. , 1997, Magnetic resonance imaging.
[107] Robert V. Mulkern,et al. Density matrix calculations of AB spectra from multipulse sequences: Quantum mechanics meets In vivo spectroscopy , 1994 .
[108] G. Barker,et al. Correction of intensity nonuniformity in MR images of any orientation. , 1993, Magnetic resonance imaging.
[109] M. Resnick,et al. Magnetic resonance imaging of the prostate. , 1987, Progress in clinical and biological research.